October 17, Saturday (Day 4)
Session 1: Discovery
Describe the principles of basic immunology. Describe the process of vaccine discovery
| 15:00-15:30 | Historical overview of vaccine Discovery Professor Dr. Kenji Hirayama, Nagasaki University, Japan |
| 15:30-16:30 | Vaccines for infection control Professor Dr. Kenji Hirayama, Nagasaki University, Japan |
October 18, Sunday (Day 5)
| 09:00-10:00 | Vaccine Platform Technology and Adjuvant Development (Dr.Arakawa) Dr. Takeshi Arakawa, University of the Ryukyus, Japan |
Session 2: Pre-Clinical Development
Describe the process of pre-clinical development of vaccine
| 10:00-10:30 | CMC Dr. Takeshi Arakawa, University of the Ryukyus, Japan |
| 10:30-11:00 | Immunogenicity and protect activity assessment Dr. Takeshi Arakawa, University of the Ryukyus, Japan |
| 11:00-11:45 | Safety assessment:Toxicity test in animals: regional complications, systemic toxicity Dr. Takeshi Arakawa, University of the Ryukyus, Japan |
| 11:45-13:00 | Lunch |
Session 3: Clinical Development
Describe the process of vaccine clinical development
| 13:00-14:00 | Assessment of pre-clinical information Dr.daisuke tsuzuki |
| 14:00-14:30 | Clinical development plan Dr.daisuke tsuzuki |
| 14:30-15:30 | Dose selection and regimen Dr.daisuke tsuzuki |
| 15:30-16:30 | Case studies Professor Dr. Kenji Hirayama, Nagasaki University, Japann |
| 16:30-17:30 | Rev and Exam 3 (Module 3)s Professor Dr. Kenji Hirayama, Nagasaki University, Japan |
October 19, Monday (Day 6)
| 10:00-17:00 | Field Trip to Hisamitsu Pharmaceutical Co.,Inc Mr.Hideyuki Nakano,Hisamitsu Pharmaceutical Co.,Inc |